Apogee Therapeutics, Inc (APGE) insider trading
Every open-market stock purchase and sale by Apogee Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Carl Dambkowski (C-suite exec) sold $738K in the last 90 days.
- Last insider buy: Nimish P Shah (Insider), $15M, 12 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $174M (35 sales). Last close $135.07 on Sep 2, 2026.
Recent APGE insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 3, 2026 | Nimish P Shah (Insider) | Sold (not open market) | $911M |
| Sep 3, 2026 | Nimish P Shah (Insider) | Sold (not open market) | $236M |
| Sep 3, 2026 | Michael Thomas Henderson (CEO) | Sold (not open market) | $19.2M |
| Sep 3, 2026 | Michael Thomas Henderson (CEO) | Sold (not open market) | $17.5M |
| Sep 3, 2026 | Michael Thomas Henderson (CEO) | Sold (not open market) | $8.8M |
| Sep 3, 2026 | Jane Henderson (CFO) | Sold (not open market) | $6.3M |
| Sep 3, 2026 | Carl Dambkowski (C-suite exec) | Sold (not open market) | $6.3M |
| Sep 3, 2026 | Carl Dambkowski (C-suite exec) | Sold (not open market) | $6.1M |
| Sep 3, 2026 | Jane Henderson (CFO) | Sold (not open market) | $6.1M |
| Sep 3, 2026 | Jane Henderson (CFO) | Sold (not open market) | $4M |
| Sep 3, 2026 | Mark C. McKenna (Insider) | Sold (not open market) | $3.5M |
| Sep 3, 2026 | Carl Dambkowski (C-suite exec) | Sold (not open market) | $2.5M |
| Sep 3, 2026 | Lisa Bollinger (Insider) | Sold (not open market) | $888K |
| Sep 3, 2026 | Nimish P Shah (Insider) | Sold (not open market) | $812K |
| Sep 3, 2026 | Fairmount Funds Management LLC (Director) | Sold (not open market) | $812K |
| Sep 3, 2026 | William A Jones Jr (Insider) | Sold (not open market) | $651K |
| Sep 3, 2026 | Mark C. McKenna (Insider) | Sold (not open market) | $651K |
| Sep 3, 2026 | Jennifer A. Fox (Insider) | Sold (not open market) | $651K |
| Sep 3, 2026 | Lisa Bollinger (Insider) | Sold (not open market) | $651K |
| Sep 3, 2026 | Nimish P Shah (Insider) | Sold (not open market) | $651K |
| Sep 3, 2026 | Fairmount Funds Management LLC (Director) | Sold (not open market) | $651K |
| Sep 3, 2026 | Lisa Bollinger (Insider) | Sold (not open market) | $602K |
| Sep 3, 2026 | Nimish P Shah (Insider) | Sold (not open market) | $602K |
| Sep 3, 2026 | Mark C. McKenna (Insider) | Sold (not open market) | $602K |
| Sep 3, 2026 | Jennifer A. Fox (Insider) | Sold (not open market) | $602K |
Who's trading APGE
- Nimish P Shah, Insider: other filings, last Sep 3, 2026
- Carl Dambkowski, C-suite exec: sold $10M (26 sales), last Sep 3, 2026
- Fairmount Funds Management LLC, Director: sold $134M (1 sale), last Sep 3, 2026
- Jennifer A. Fox, Insider: other filings, last Sep 3, 2026
- Lisa Bollinger, Director: other filings, last Sep 3, 2026
- Michael Thomas Henderson, CEO: sold $28.4M (33 sales), last Sep 3, 2026
- Jane Henderson, CFO: sold $2.1M (21 sales), last Sep 3, 2026
- William A Jones Jr, Insider: other filings, last Sep 3, 2026
- Mark C. McKenna, Director: other filings, last Sep 3, 2026
Get free alerts when an insider at Apogee Therapeutics, Inc files a new trade →